导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.74% | 933/1050 |
| 近一周 | -2.28% | 761/1104 |
| 近一月 | -2.72% | 486/1103 |
| 近一季 | 2.70% | 187/1092 |
| 近半年 | -11.83% | 825/1070 |
| 近一年 | -22.80% | 940/1018 |
| 近两年 | 12.96% | 827/926 |
| 近三年 | 1.37% | 671/834 |
| 成立以来 | 95.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.82% 996/1070 |
-10.85% 932/1101 |
- - |
- - |
| 2025 | 6.64% 861/1065 |
5.77% 356/1014 |
5.78% 256/1038 |
1.55% 982/1050 |
-6.14% 748/1065 |
| 2024 | 16.35% 146/1011 |
2.63% 181/960 |
-3.35% 538/983 |
19.95% 67/991 |
-2.21% 470/1011 |
| 2023 | 1.19% 83/952 |
9.04% 141/880 |
-1.04% 241/895 |
-2.49% 178/915 |
-3.82% 393/952 |
| 2022 | -11.38% 101/867 |
-20.46% 541/773 |
4.43% 553/806 |
-12.68% 438/845 |
22.18% 10/867 |
| 2021 | -0.03% 352/740 |
-5.06% 340/580 |
8.58% 397/659 |
-14.91% 609/704 |
13.97% 32/740 |
| 2020 | 54.09% 221/554 |
4.56% 79/419 |
13.35% 373/466 |
23.82% 24/517 |
5.01% 439/554 |
| 2019 | - - |
- - |
5.07% 43/1228 |
2.52% 266/390 |
9.42% 178/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国泰消费优选股票 VS. 东吴新产业精选股票A(580008) |